scholarly journals Visualizing Patterns of Medication Switching Among Major Depressive Patients with Various Stability and Difficulty to Treatments

2021 ◽  
Vol Volume 17 ◽  
pp. 1953-1963
Author(s):  
Yu-Chun Hung ◽  
Hsi-Chung Chen ◽  
Po-Hsiu Kuo ◽  
Mong-Liang Lu ◽  
Ming-Chyi Huang ◽  
...  
Keyword(s):  
Major Depressive ◽  
Depressive Patients ◽  
Medication Switching

Factors associated with borderline personality disorder in major depressive patients and their relationship to bipolarity

2013 ◽  
Vol 28 (8) ◽  
pp. 463-468 ◽  
Author(s):  
J.M. Azorin ◽  
A. Kaladjian ◽  
M. Adida ◽  
E. Fakra ◽  
R. Belzeaux ◽  
...  
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Age At Onset ◽  
Borderline Personality ◽  
First Episode ◽  
Contributory Factor ◽  
Structured Interviews ◽  
Major Depressive ◽  
History Of ◽  
Depressive Patients

AbstractObjectiveTo analyze the interface between borderline personality disorder (BPD) and bipolarity in depressed patients comorbid with BPD.MethodsAs part of National Multi-site Study of 493 consecutive DSM-IV major depressive patients evaluated in at least two semi-structured interviews 1 month apart, 19 (3.9%) had comorbid BPD (BPD+), whereas 474 (96.1%) did not manifest this comorbidity (BPD−).ResultsCompared to BPD (−), BPD (+) patients displayed higher rates of bipolar (BP) disorders and temperaments, an earlier age at onset with a family history of affective illness, more comorbidity, more stressors before the first episode which was more often depressive or mixed, as well as a greater number and severity of affective episodes.ConclusionsThe hypothesis which fitted at best our findings was to consider BPD as a contributory factor in the development of BP disorder, which could have favoured the progression from unipolar major depression to BP disorder. We could not however exclude that some features of BP disorder may have contributed to the development of BPD.

Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients

2005 ◽  
Vol 20 (3) ◽  
pp. A16
Author(s):  
Shingo Naito ◽  
Kazuhiro Sato ◽  
Hisashi Higuchi ◽  
Keizo Yoshida ◽  
Hitoshi Takahashi ◽  
...  
Keyword(s):  
Gender Differences ◽  
Clinical Effects ◽  
Major Depressive ◽  
Depressive Patients

scholarly journals Erratum: CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients

2012 ◽  
Vol 18 (2) ◽  
pp. 266-266 ◽  
Author(s):  
E M Peñas-LLedó ◽  
H D Trejo ◽  
P Dorado ◽  
A Ortega ◽  
H Jung ◽  
...  
Keyword(s):  
Major Depressive ◽  
Early Dropout ◽  
Depressive Patients

scholarly journals Repeated use of SSRIs potentially associated with an increase on serum CK and CK-MB in patients with major depressive disorder: a retrospective study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Shengwei Wu ◽  
Yufang Zhou ◽  
Zhengzheng Xuan ◽  
Linghui Xiong ◽  
Xinyu Ge ◽  
...  
Keyword(s):  
Creatine Kinase ◽  
Major Depressive Disorder ◽  
Retrospective Study ◽  
Depressive Disorder ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Cardiac Injury ◽  
First Episode ◽  
Cardiovascular Risks ◽  
Major Depressive ◽  
Depressive Patients

AbstractThere is a large amount of evidence that selective serotonin reuptake inhibitors (SSRIs) are related to cardiovascular toxicity, which has aroused concern regarding their safety. However, few studies have evaluated the effects of SSRIs on cardiac injury biomarkers, such as creatine kinase (CK) and creatine kinase isoenzyme (CK-MB). The purpose of our study was to determine whether SSRIs elevated CK and CK-MB levels of prior medicated depressive patients (PMDP) compared to first-episode drug-naïve depressive patients (FDDPs). We performed an observational and retrospective study involving 128 patients with major depressive disorder. Patients who had never used any type of antidepressant were designated FDDP; patients who had used only one type of SSRI but were not treated after a recent relapse were designated PMDP. Serum CK and CK-MB levels were measured before and after using SSRIs for a period of time. The duration of current treatment in the FDDP and PMDP groups was 16.200 ± 16.726 weeks and 15.618 ± 16.902 weeks, respectively. After SSRI treatment, levels of serum CK in the PMDP group were significantly higher than in the FDDP group. Univariate ANCOVA results revealed that PMDP was 22.313 times more likely to elevate CK (OR 22.313, 95% CI 9.605–35.022) and 2.615 times more likely to elevate CK-MB (OR 2.615, 95% CI 1.287–3.943) than FDDP. Multivariate ANCOVA revealed an interaction between the group and sex of CK and CK-MB. Further pairwise analysis of the interaction results showed that in female patients, the mean difference (MD) of CK and CK-MB in PMDP was significantly greater than that in FDDP (MD = 33.410, P = 0.000, 95% CI 15.935–50.886; MD = 4.613, P = 0.000, 95% CI 2.846–6.381). Our findings suggest that patients, especially females, who had previously used SSRI antidepressants were more likely to have elevated CK and CK-MB, indicators of myocardial muscle injury. Use of SSRIs should not be assumed to be completely safe and without any cardiovascular risks.

Detecting Underdiagnosed Hypomania in Major Depressive Patients

2015 ◽  
Vol 30 ◽  
pp. 1133
Author(s):  
K. Hajbi ◽  
I. Baati ◽  
S. Ellouze ◽  
I. Feki ◽  
D. Trigui ◽  
...  
Keyword(s):  
Major Depressive ◽  
Depressive Patients

Visual flicker in depression: response criteria, confidence ratings and response times

1986 ◽  
Vol 16 (1) ◽  
pp. 187-197 ◽  
Author(s):  
Joseph E. Herskovic ◽  
Mitchell L. Kietzman ◽  
Samuel Sutton
Keyword(s):  
Signal Detection ◽  
Response Times ◽  
The Other ◽  
Response Criterion ◽  
Sensory Sensitivity ◽  
Major Depressive ◽  
Depressed Patients ◽  
Depressive Patients ◽  
Normal Controls ◽  
Confidence Ratings

SynopsisDifferences in response criterion and sensory sensitivity to visual flicker among major depressive patients, dysthymic patients, and normal controls were investigated. Also, signal detection confidence ratings and response times were compared. The results indicated that major depressive patients responded more conservatively (i.e. were less willing to respond ‘flicker’) than either of the other groups. The groups did not differ significantly on a criterion free measure of flicker sensitivity. The major conclusions are: (1) previously reported visual flicker differences between depressed patients and normal controls were probably due to the more conservative response criterion of the patients and not to flicker sensitivity differences between groups; and (2) confidence ratings and response times yield similar conclusions with respect to visual flicker sensitivity and response criterion. Therefore, interpretations concerning a sensory or perceptual deficit in depression must take into account the differences in response criterion between depressed patients and normal controls.

Sign in / Sign up

Export Citation Format

Share Document